JP2005536467A - 選択的ｉＮＯＳ阻害剤を用いる呼吸器の疾患および状態の治療方法 - Google Patents

選択的ｉＮＯＳ阻害剤を用いる呼吸器の疾患および状態の治療方法 Download PDF

Info

Publication number
JP2005536467A
JP2005536467A JP2004505156A JP2004505156A JP2005536467A JP 2005536467 A JP2005536467 A JP 2005536467A JP 2004505156 A JP2004505156 A JP 2004505156A JP 2004505156 A JP2004505156 A JP 2004505156A JP 2005536467 A JP2005536467 A JP 2005536467A
Authority
JP
Japan
Prior art keywords
alkyl
optionally substituted
group
amino
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2004505156A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005536467A5 (https=
Inventor
パメラ・ティー・マニング
Original Assignee
ファルマシア・コーポレーション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ファルマシア・コーポレーション filed Critical ファルマシア・コーポレーション
Publication of JP2005536467A publication Critical patent/JP2005536467A/ja
Publication of JP2005536467A5 publication Critical patent/JP2005536467A5/ja
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP2004505156A 2002-05-16 2003-05-16 選択的ｉＮＯＳ阻害剤を用いる呼吸器の疾患および状態の治療方法 Abandoned JP2005536467A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38105402P 2002-05-16 2002-05-16
PCT/US2003/015369 WO2003097163A2 (en) 2002-05-16 2003-05-16 Using a selective inos inhibitor for the treatment of respiratory diseases and conditions

Publications (2)

Publication Number Publication Date
JP2005536467A true JP2005536467A (ja) 2005-12-02
JP2005536467A5 JP2005536467A5 (https=) 2006-07-06

Family

ID=29550060

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004505156A Abandoned JP2005536467A (ja) 2002-05-16 2003-05-16 選択的ｉＮＯＳ阻害剤を用いる呼吸器の疾患および状態の治療方法

Country Status (13)

Country Link
US (1) US20040077639A1 (https=)
EP (1) EP1506040A2 (https=)
JP (1) JP2005536467A (https=)
KR (1) KR20050004155A (https=)
CN (1) CN1652843A (https=)
AU (1) AU2003234606A1 (https=)
BR (1) BR0311180A (https=)
CA (1) CA2486061A1 (https=)
IL (1) IL164826A0 (https=)
MX (1) MXPA04011404A (https=)
PL (1) PL373952A1 (https=)
WO (1) WO2003097163A2 (https=)
ZA (1) ZA200408905B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006519839A (ja) * 2003-03-11 2006-08-31 ファルマシア・コーポレーション Ｓ−［２−［（１−イミノエチル）アミノ］エチル］−２−メチル−ｌ−システインマレエートｉｉ型結晶塩
WO2004080953A1 (en) * 2003-03-11 2004-09-23 Pharmacia Corporation S-[2-[(1-iminoethyl)amino]ethyl]-2-methyl-l-cysteine salicylate monohydrate crystalline salt
CN101068559B (zh) * 2004-07-23 2011-08-31 福生生物科技股份有限公司 红球姜的抗超敏炎症和抗敏活性
TWI375671B (en) * 2010-03-01 2012-11-01 Univ China Medical Pharmaceutical compositions containing brazilin for inhibiting expression of cytokines of t helper cell type ii and/or inhibiting expression of chemokines and uses of the same
EP2591777B1 (de) * 2010-07-09 2016-12-14 Justus-Liebig-Universität Gießen L-NIL als Inhibitor zur Regeneration der Lunge von an COPD leidenden Patienten
AU2018332634A1 (en) 2017-09-12 2020-04-30 Agency For Science, Technology And Research Compounds useful as inhibitors of isoprenylcysteine carboxyl methyltransferase
CN116554142A (zh) * 2023-05-11 2023-08-08 江苏省中医药研究院 一种治疗过敏性哮喘的蝉蜕乙酰多巴胺寡聚体组合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262784B1 (en) * 1993-06-01 2001-07-17 Samsung Electronics Co., Ltd Active matrix display devices having improved opening and contrast ratios and methods of forming same and a storage electrode line
US5824669A (en) * 1996-03-22 1998-10-20 Nitromed, Inc. Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
US6331543B1 (en) * 1996-11-01 2001-12-18 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
AU6823098A (en) * 1997-02-28 1998-09-18 Byk Gulden Lomberg Chemische Fabrik Gmbh Synergistic combination of pde inhibitors and adenylate cyclase agonists or guanyl cyclyse agonists
GB9811599D0 (en) * 1998-05-30 1998-07-29 Glaxo Group Ltd Nitric oxide synthase inhibitors
DK1265859T3 (da) * 2000-03-24 2006-05-01 Pharmacia Corp Amidinoforbindelser der er nyttige som nitrogenoxidsyntaseinhibitorer
US6545170B2 (en) * 2000-04-13 2003-04-08 Pharmacia Corporation 2-amino-5, 6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
AR032318A1 (es) * 2000-04-13 2003-11-05 Pharmacia Corp Compuesto derivado halogenado del acido 2-amino-5,6 heptenoico; composicion farmaceutica que lo comprende y su uso en la fabricacion de un medicamento util como inhibidor de la oxido nitrico sintetasa
WO2002010139A1 (en) * 2000-08-01 2002-02-07 Pharmacia Corporation Hexahydro-7-1h-azepin-2-yl-haxanoic acid derivatives as inhibitors of inducible nitric oxide synthase
MY131964A (en) * 2000-09-15 2007-09-28 Pharmacia Corp 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
AR035585A1 (es) * 2000-09-15 2004-06-16 Pharmacia Corp Derivados del acido 2-amino-2-alquil-4-heptenoico, composicion farmaceutica y su uso en la fabricacion de medicamentos
AR031609A1 (es) * 2000-09-15 2003-09-24 Pharmacia Corp Derivados de acido 2-amino-2-alquil-3 heptenoico y heptinoico utiles como inhibidores de oxido nitrico sintetasa

Also Published As

Publication number Publication date
CN1652843A (zh) 2005-08-10
WO2003097163A3 (en) 2004-10-21
EP1506040A2 (en) 2005-02-16
US20040077639A1 (en) 2004-04-22
KR20050004155A (ko) 2005-01-12
BR0311180A (pt) 2005-03-01
IL164826A0 (en) 2005-12-18
AU2003234606A1 (en) 2003-12-02
WO2003097163A2 (en) 2003-11-27
CA2486061A1 (en) 2003-11-27
PL373952A1 (en) 2005-09-19
MXPA04011404A (es) 2005-02-14
ZA200408905B (en) 2006-06-28

Similar Documents

Publication Publication Date Title
US20130281449A1 (en) Oxazine Derivatives and their Use in the Treatment of Neurological Disorders
US20230024914A1 (en) Methods of treating respiratory disorders
CN101959429A (zh) 抗微生物肽系统的激动剂
US7012098B2 (en) Inhibitors of inducible nitric oxide synthase for chemoprevention and treatment of cancers
JP2005532321A (ja) 呼吸器の疾患および状態の、選択的ｉＮＯＳ阻害剤とＰＤＥ阻害剤による治療方法、ならびにそのための組成物
JP2022513915A (ja) 新規化合物及びそれらの治療における使用
WO2021158954A1 (en) Nitric oxide-releasing antibacterial compounds, formulations, and methods pertaining thereto
US20220281846A1 (en) Compounds and compositions for the treatment of respiratory diseases
CA3176909A1 (en) Compositions and methods for the prevention and/or treatment of mitochondrial disease, including friedreich's ataxia
US20050203082A1 (en) Combination therapy with inhibitors of inducible nitric oxide synthase and alkylating agents
JP2005508910A (ja) 選択的ｉＮＯＳ阻害剤を用いる神経保護的な治療方法
JP2004500344A (ja) 低酸素分圧状態における内因性一酸化窒素の合成
JP2005536467A (ja) 選択的ｉＮＯＳ阻害剤を用いる呼吸器の疾患および状態の治療方法
KR20050059051A (ko) 위장 증상의 치료 및 예방 방법
KR20040039393A (ko) 선택적 ｉｎｏｓ 억제제를 사용한 안과적 치료 방법
JP2005506986A5 (https=)
HK1076061A (en) Using a selective inos inhibitor for the treatment of respiratory diseases and conditions
JP2021536467A (ja) 喘息またはパーキンソン病の処置のための方法および組成物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060516

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060516

A762 Written abandonment of application

Free format text: JAPANESE INTERMEDIATE CODE: A762

Effective date: 20080130

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20080130